Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 Nov 7, 2025
Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. Aug 20, 2025
Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth Jun 30, 2025
